Sharma Mani's Form 4 filing
AstraZeneca PLC (AZN) · filed Aug 7, 2026
- Accession no.
- 0002122411-26-000001
- Filed
- Aug 7, 2026, 11:40 AM ET
- Trade date
- Aug 6, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sharma ManiCIK 0002122411 | Officer (SVP, Group Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Ordinary Shares | AGrant or awardAcquired | +2 | $163.34F1 | +$326.68 | 19,267.4659 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP121.26, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3470 on July 31, 2026 as published by the Board of Governors of the Federal Reserve System.
Referenced by the price of 1 transaction in Table I.